< Back to companies
Smart Opinion

Smart Opinion

Tokyo, Japan

Smart Opinion is a healthcare technology startup developing AI-powered breast cancer screening solutions. The company specializes in enhancing the accuracy and accessibility of breast ultrasound (echo) examinations through its AI diagnostic tool, 'Smaopi' (スマオピ), which supports radiologists by analyzing breast ultrasound images to detect suspected cancer. The system aims to improve early detection rates by combining human expertise with artificial intelligence, making screening more comfortable, reliable, and widely accessible. The company is focused on increasing screening participation and normalizing early breast cancer detection.

Only accessible to MedStartr community members. Join now

Company Info

Website
www.smaopi.com/
Only accessible to MedStartr community members. Join now

What do you think of Smart Opinion?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now